General Information
Drug ID
DR00101
Drug Name
Edaravone
Synonyms
(MCI-186); 1-Fenyl-3-methyl-2-pyrazolin-5-on; 1-Fenyl-3-methyl-2-pyrazolin-5-on [Czech]; 1-Phenyl-3-methyl-5-oxo-2-pyrazoline; 1-Phenyl-3-methyl-5-pyrazolone; 1-Phenyl-3-methylpyrazolone; 1-Phenyl-3-methylpyrazolone-5; 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one; 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE; 3-Methyl-1-phenyl-2-pyrazoline-5-one; 3-Methyl-1-phenyl-5-pyrazolone; 3-Methyl-1-phenylpyrazol-5-one; 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one; 5-methyl-2-phenyl-4H-pyrazol-3-one; AE-641/00371017; C.I. Developer 1; CDS1_000986; CI Developer 1; Developer Z; Edarabone; Edaravone; Edaravone (JAN/INN); Edaravone [INN]; Edaravone(jan); IN1263; M0687; MCI 186; Methylphenylpyrazolone; Monopyrazolone; Norantipyrine; Norphenazone; Phenyl methyl pyrazolone; Phenylmethylpyrazolone; Radicut; Radicut (TN)
Drug Type
Small molecular drug
Indication Amyotrophic lateral sclerosis [ICD11: 8B60.0] Approved [1]
Structure
3D MOL 2D MOL
Formula
C10H10N2O
Canonical SMILES
CC1=NN(C(=O)C1)C2=CC=CC=C2
InChI
InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3
InChIKey
QELUYTUMUWHWMC-UHFFFAOYSA-N
CAS Number
CAS 89-25-8
Pharmaceutical Properties Molecular Weight 174.2 Topological Polar Surface Area 32.7
Heavy Atom Count 13 Rotatable Bond Count 1
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 2
XLogP
1.3
PubChem CID
4021
PubChem SID
10537545 , 11113339 , 11120318 , 11120806 , 11121294 , 11121793 , 11122273 , 11336193 , 11337201 , 11361432 , 11362989 , 11363161 , 11365551 , 11365723 , 11368113 , 11368285 , 11371129 , 11371130 , 11371920 , 11373714 , 11374640 , 11376275 , 11376447 , 11384009 , 11462404 , 11485244 , 11489390 , 11490786 , 11492905 , 11494081 , 11512560 , 12014003 , 15219562 , 16959864 , 17389763 , 22389521 , 24885706 , 24897140 , 25622932 , 26612506 , 3133945 , 5663208 , 583397 , 66965 , 69252 , 7848615 , 8150018 , 8152519 , 855774 , 87060
ChEBI ID
ChEBI:31530
TTD Drug ID
D06DLI
DT(s) Transporting This Drug OAT1 Transporter Info Organic anion transporter 1 Substrate [2]
OAT3 Transporter Info Organic anion transporter 3 Substrate [2]
Drug-Transporter Activity Data
Drug-Transporter Activity Data OAT1 Transporter Info Km = 10.8 microM Human embryonic kidney cells (HEK293)-OAT1 [2]
OAT3 Transporter Info Km = 15.1 microM Human embryonic kidney cells (HEK293)-OAT3 [2]
References
1 Edaravone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate. Drug Metab Dispos. 2007 Aug;35(8):1429-34.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.